ES2 10MG

AOD9604 is a modified version of the hGH fragment 176-191 peptide (contains a di-sulfide bridge) and thus a derivative of human growth hormone (hGH). Originally developed as a lipolytic (fat burning) compound, AOD9604 has shown benefit in studies of heart disease, osteoarthritis/cartilage repair, and metabolic syndrome. AOD9604 stimulates lipolysis (the breakdown or destruction of fat) and inhibits lipogenesis in animal studies.

Delta-sleep-inducing peptide is a neuropeptide that affects a number of endocrine and physiological processes within the central nervous system. DSIP is of primary interest for its abilities to reduce oxidative stress, normalize myocardial contractility. It is also being studied as a potential target in the treatment of major depressive disorder.

Epithalon (Epitalon) is a synthetic derivative of Epithalamin and a potential modulator of telomerase, the enzyme that maintains and protects the telomere caps at the ends of chromosomes (strands of DNA). Research suggests that Epithalon induces telomere elongation and may fight off the effects of aging as a result.

KPV is a potent anti-inflammatory peptide that has shown promise in a number of disease conditions. The most active research is in the treatment of inflammatory bowel disease where the peptide has showed substantial promise. Research in wound healing also reveals that KPV and other alpha-MSH derivatives may offer a host of benefits that speed wound healing, reduce infection, fight inflammation, and lead to better cosmetic results. KPV and similar peptides could become mainstays not just in wound healing, but in scar reduction following surgery.

MOTS-c is a mitochondrial-derived peptide (MDP) composed of 16 amino acids, which plays a critical role in cellular metabolic regulation. Synthesized within mitochondria, MOTS-c functions by modulating the cellular energy balance through pathways involved in glucose metabolism, insulin sensitivity, and cellular stress response.  MOTS-c exerts its effects by translocating to the nucleus, where it influences the expression of genes related to mitochondrial biogenesis and metabolic regulation, particularly under conditions of metabolic stress. Research has shown this peptide to improve exercise capacity, reduce obesity, insulin resistance and other disease processes such as osteoporosis and the mitigation of metabolic disorders and age-associated diseases. The Mitochondrial-Derived Peptide MOTS-c promotes metabolic homeostasis and longevity, improves exercise capacity, reduces obesity, insulin resistance and other disease processes such as osteoporosis.